Join our Investor Webinar on the 3rd December 18:00-19:30, with speakers from Sunda Energy and Blencowe Resources. Please register here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 374.50
Bid: 375.50
Ask: 375.70
Change: -18.70 (-4.76%)
Spread: 0.20 (0.053%)
Open: 394.00
High: 394.10
Low: 374.20
Prev. Close: 393.20

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Marks and Spencer Group Investor Presentation

12 Oct 2022 12:00

RNS Number : 6529C
Marks and Spencer Group PLC
12 October 2022
 

Marks and Spencer Group Investor Presentation

NEW M&S LEADERSHIP SETS OUT "RESHAPING FOR GROWTH" PLANS

Marks and Spencer Group PLC is holding an investor presentation today for institutional shareholders and analysts at which its new leadership team, led by Stuart Machin and Katie Bickerstaffe, will set out a number of strategic ambitions to reshape the business for growth, whilst increasing resilience from strengthened foundations. Against the background of adverse macro-economic conditions, M&S is increasing the pace of change to create a higher productivity business reducing costs, increasing margins and shifting volume into growth categories and channels.

The presentation for the day will be available on our corporate website at 12pm UK time at Results Reports Webcasts & Presentations | Marks & Spencer (marksandspencer.com) and a replay webcast of the event will be available later in the day. There will be no update on current trading performance or our financial results. M&S will next update the market at its interim results presentation on November 9th.

 

For further information, please contact:

Investor Relations:

Fraser Ramzan: +44 (0) 7554 227758

Jack Cook:  +44 (0) 20 3882 5535

 

Media enquiries:

Corporate Press Office: +44 (0) 20 8718 1919

 

 

-Ends-

Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences and prospects are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect Marks & Spencer's current expectations concerning future events and actual results may differ materially from current expectations or historical results. Any forward-looking statements are subject to various risks and uncertainties, including, but not limited to, failure by Marks & Spencer to predict accurately customer preferences; decline in the demand for products offered by Marks & Spencer; competitive influences; changes in levels of store traffic or consumer spending habits; effectiveness of Marks & Spencer's brand awareness and marketing programmes; general economic conditions including, but not limited to, those related to the Covid-19 pandemic or a downturn in the retail or financial services industries; acts of war or terrorism worldwide; work stoppages, slowdowns or strikes; and changes in financial and equity markets. For further information regarding risks to Marks & Spencer's business, please consult the risk management section of the 2022 Annual Report (pages 45-54).

The forward-looking statements contained in this document speak only as of the date of this announcement, and Marks & Spencer does not undertake to update any forward-looking statement to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKLLBFLBLEFBZ
Date   Source Headline
6th Nov 20247:00 amRNSHalf-year Report
1st Nov 20249:00 amRNSTotal Voting Rights
29th Oct 20243:32 pmRNSDirector/PDMR Shareholding
1st Oct 20249:00 amRNSTotal Voting Rights
30th Sep 202412:35 pmRNSDirector/PDMR Shareholding
26th Sep 202410:05 amRNSDirectorate Change
18th Sep 202411:53 amRNSDirector/PDMR Shareholding
2nd Sep 20249:00 amRNSTotal Voting Rights
30th Aug 202410:37 amRNSDirector/PDMR Shareholding
29th Aug 20249:00 amRNSDirector/PDMR Shareholding
20th Aug 202411:05 amRNSDirector/PDMR Shareholding
8th Aug 202411:30 amRNSConfirmation of CFO appointment date
1st Aug 20249:00 amRNSTotal Voting Rights
31st Jul 20249:00 amRNSDirector/PDMR Shareholding
8th Jul 20242:37 pmRNSDirector/PDMR Shareholding
3rd Jul 20244:45 pmRNSDirectorate Change
3rd Jul 20244:11 pmRNSDirector/PDMR Shareholding
2nd Jul 20241:30 pmRNSResult of AGM
1st Jul 20249:00 amRNSTotal Voting Rights
1st Jul 20249:00 amRNSBlock listing Interim Review
28th Jun 20245:55 pmRNSDirector/PDMR Shareholding
27th Jun 20244:51 pmRNSHolding(s) in Company
25th Jun 202411:26 amRNSDirector Declaration
3rd Jun 202410:00 amRNSAnnual Financial Report
3rd Jun 20249:00 amRNSTotal Voting Rights
30th May 202412:41 pmRNSDirector/PDMR Shareholding
29th May 20244:01 pmRNSCFO announcement
29th May 20242:07 pmRNSDirector/PDMR Shareholding
28th May 20242:04 pmRNSAndrew Fisher to stand down from the Board
22nd May 20247:00 amRNSFinal Results
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20241:13 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.